Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,430 | -51,207 | -41,823 | -65,354 | -55,238 |
| Depreciation Amortization | 404 | 466 | 528 | 622 | 614 |
| Accounts payable and accrued liabilities | -2,234 | 150 | 4,627 | -472 | 211 |
| Other Working Capital | -11,483 | 2,405 | 3,771 | 961 | -262 |
| Other Operating Activity | 2,766 | 3,596 | 575 | 20,939 | 20,784 |
| Operating Cash Flow | $-35,977 | $-44,590 | $-32,322 | $-43,304 | $-33,891 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 18 | -29 | -24 | -212 | -79 |
| Purchase Of Investment | N/A | N/A | 30,090 | N/A | 12,707 |
| Sale Of Investment | N/A | 9,989 | N/A | -34,996 | N/A |
| Investing Cash Flow | $18 | $9,960 | $30,066 | $-35,208 | $12,628 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 23,414 | 6,910 | 116 | 226 | 58,975 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -168 |
| Financing Cash Flow | $33,414 | $6,910 | $116 | $226 | $58,807 |
| Exchange Rate Effect | N/A | 2 | -4 | 7 | 7 |
| Beginning Cash Position | 9,252 | 36,970 | 39,114 | 117,393 | 79,842 |
| End Cash Position | 6,707 | 9,252 | 36,970 | 39,114 | 117,393 |
| Net Cash Flow | $-2,545 | $-27,718 | $-2,144 | $-78,279 | $37,551 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,977 | -44,590 | -32,322 | -43,304 | -33,891 |
| Capital Expenditure | -5 | -29 | -24 | -212 | -79 |
| Free Cash Flow | -35,982 | -44,619 | -32,346 | -43,516 | -33,970 |